Clinical trial · Observational
EUS-guided Ablation of Pancreatic Cyst Neoplasms
Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cyst Neoplasms
NCT02422147CI-TRIAL-00083822completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a registry that will maintain prospective data on the clinical outcomes of all patients with pancreatic cyst lesions who undergo EUS-guided alcohol ablation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Cyst | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ablation of PCL | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Ablation of PCL
- description
- Patients with pancreatic cysts will undergo ablation using alcohol under EUS-guidance
- interventionNames
- Procedure: Ablation of PCL
Primary outcomes (1)
- measure
- This study will evaluate the clinical outcomes (effectiveness) of all patients with pancreatic cyst lesions undergoing EUS-guided ethanol ablation. This will include complete resolution of the pancreatic cyst lesion at the end of the treatment period.
- timeFrame
- Up to 12 months
- description
- Clinical outcomes
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Benign branch-duct intraductal papillary mucinous neoplasm (IPMN) or mucinous cyst neoplasm (MCN) measuring \>2 and up to 4cm in size and located in the head or body of the pancreas. 2. Benign branch-duct IPMN or MCN measuring \> 2 and up to 4cm in size and located in the tail of the pancreas in a high-risk surgical candidate. 3. A branch-duct IPMN or MCN with high-risk features (mural nodule or enlarging in size) in a high-risk surgical patient. 4. Indeterminate cyst lesions Exclusion Criteria: 1. Cysts measuring \<2cm or \>4cm. 2. Multiloculated cysts (\>4 locules). 3. Cysts with vascular supply. 4. Cysts communicating with the main pancreatic duct via an obvious side-branch measuring 2mm or more in diameter. 5. Cysts with hypoechoic mass lesions that on fine needle aspiration (FNA)reveal malignant cells. 6. Recent history of pancreatitis and EUS findings suggestive of a pseudocyst. 7. Bleeding tendency; international normalized ratio (INR) \>1.4 or platelet count \<70,000.
References
Publications (0)
Data not yet available
No reference posted for this study.